CLOSE
MENU

Chordia Therapeutics Inc.
Investor Relations

Investor Relations

Investor Relations

Top Message

Top Message

Financial Highlights

Financial Highlights

IR News

May 15, 2025 Notice Concerning Change of Major Shareholder （249KB）
Apr 28, 2025 Notice of Discontinuation of Development of CTX-177 (ONO-7018) （289KB）
Apr 25, 2025 Chordia presents new data at the American Association for Cancer Research Annual Meeting 2025 （229KB）
Apr 24, 2025 Notice of Release of Transcript of Interim Financial Results Briefing for the Fiscal Year Ending August 31, 2025 （276KB）
Apr 11, 2025 For 2nd quarter FY8 2025 Financial Results Presentation （1,132KB）

IR News

IR Calenar

Ｍid-Jul-24
Announcement of 3Q Financial results of FY2025

Latest financial statements

複製用パーツ：20XX年X月期第X四半期　（英文：FY20XX QX）

FY2025 （0KB）

FY2025　2Q

Financial Results (Transcript) （3,003KB）

FY2024

Fiscal year ended August 2024 Financial Results (Transcript) （2,714KB）

FY2025 (2Q): Non-consolidated Financial Results for the Six Months Ended February 28, 2025 [Japanese GAAP] （442KB）; For 2nd quarter FY8 2025 Financial Results Presentation （1,132KB）

FY2025 (1Q): Non-consolidated Financial Results for the Three Months Ended November 30, 2024 [Japanese GAAP] （432KB）

FY2024: Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2024 [Japanese GAAP] （538KB）; Fiscal year ended August 2024 Financial Results Presentation （1,465KB）

FY2024 (3Q): Non-consolidated Financial Results for the Nine Months Ended May 31, 2024 [Japanese GAAP] （348KB）

Management Policies

Financial Information

IR Library

Financial Results

Stock Information

IR Calender

IR FAQ

Disclaimer

ページの先頭へ

ページの先頭へ

footer-content

menu

gnavi-box